NCT05041439

Brief Summary

Given the magnitude of the epidemic in Puerto Rico, congenital Zika virus infection may have devastating complications to a significant population of children, also affecting families and society at large. This proposal takes a critical first step to ensuring that children with exposure to congenital Zika virus infection receive the follow-up care they need for optimal clinical outcomes. We anticipate that lessons learned from this study may also positively impact models for adherence to early intervention services in Puerto Rico.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 6, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 13, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2022

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

December 15, 2023

Completed
Last Updated

December 15, 2023

Status Verified

November 1, 2023

Enrollment Period

1.2 years

First QC Date

September 2, 2021

Results QC Date

August 27, 2023

Last Update Submit

November 25, 2023

Conditions

Keywords

Zika virusPuerto Ricocommunity health worker

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Adherence to Pediatric Zika Care

    At least one pediatric visit for developmental exam with the pediatrician within 6 months post-randomization.

    Within the first 6 months

Secondary Outcomes (3)

  • Number of Participants With Detection of Zika-associated Birth Defect or Neurodevelopmental Abnormality

    Within the first 6 months

  • Number of Participants With Adherence to Pediatric Zika Care

    Within the first 12 months

  • Number of Participants With Detection of Zika-associated Birth Defect or Neurodevelopmental Abnormality

    Within the first 12 months

Study Arms (2)

Community health worker (CHW) group

EXPERIMENTAL

Participants in the intervention arm will receive 5 one-on-one sessions over 6 months with a CHW, as well as a manual and written materials on child development. At baseline and exit, all participants will be assessed using instruments to measure demographics and self-perceived barriers.

Behavioral: Community Health Worker

Enhanced care condition (ECC)

NO INTERVENTION

Participants in this arm will receive 5 outreach calls at the same interval as the intervention arm, as well as written materials on child development. At baseline and exit, all participants will be assessed using instruments to measure demographics and self-perceived barriers.

Interventions

Participants will receive 5 one-on-one sessions with a CHW over 6 months.

Community health worker (CHW) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older and able to communicate in Spanish
  • Being the primary caregiver of a child with possible congenital Zika virus infection

You may not qualify if:

  • Those who are too sick/unable to understand the implications of their participation, those who are unwilling to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Medicine - Department of Pediatrics

San Juan, PR, 00921, Puerto Rico

Location

MeSH Terms

Conditions

Zika Virus InfectionPatient Compliance

Interventions

Community Health Workers

Condition Hierarchy (Ancestors)

Mosquito-Borne DiseasesVector Borne DiseasesInfectionsArbovirus InfectionsVirus DiseasesFlavivirus InfectionsFlaviviridae InfectionsRNA Virus InfectionsPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Allied Health PersonnelHealth PersonnelHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Dr. Julie H Levison
Organization
Massachusetts General Hospital

Study Officials

  • Julie H. Levison, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Physician

Study Record Dates

First Submitted

September 2, 2021

First Posted

September 13, 2021

Study Start

July 6, 2021

Primary Completion

August 31, 2022

Study Completion

November 6, 2022

Last Updated

December 15, 2023

Results First Posted

December 15, 2023

Record last verified: 2023-11

Locations